Assessing secondhand smoke using biological markers
Open Access
- 2 September 2012
- journal article
- review article
- Published by BMJ in Tobacco Control
- Vol. 22 (3), 164-171
- https://doi.org/10.1136/tobaccocontrol-2011-050298
Abstract
Secondhand smoke exposure (SHSe) is a known cause of many adverse health effects in adults and children. Increasingly, SHSe assessment is an element of tobacco control research and implementation worldwide. In spite of decades of development of approaches to assess SHSe, there are still unresolved methodological issues; therefore, a multidisciplinary expert meeting was held to catalogue the approaches to assess SHSe and with the goal of providing a set of uniform methods for future use by investigators and thereby facilitate comparisons of findings across studies. The meeting, held at Johns Hopkins, in Baltimore, Maryland, USA, was supported by the Flight Attendant Medical Research Institute (FAMRI). A series of articles were developed to summarise what is known about self-reported, environmental and biological SHSe measurements. Non-smokers inhale toxicants in SHS, which are mainly products of combustion of organic materials and are not specific to tobacco smoke exposure. Biomarkers specific to SHSe are nicotine and its metabolites (eg, cotinine), and metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cotinine is the preferred blood, saliva and urine biomarker for SHSe. Cotinine and nicotine can also be measured in hair and toenails. NNAL (4-[methylnitrosamino]-1-[3-pyridyl]-1-butanol), a metabolite of NNK, can be determined in the urine of SHS-exposed non-smokers. The selection of a particular biomarker of SHSe and the analytic biological medium depends on the scientific or public health question of interest, study design and setting, subjects, and funding. This manuscript summarises the scientific evidence on the use of biomarkers to measure SHSe, analytical methods, biological matrices and their interpretation.Keywords
This publication has 87 references indexed in Scilit:
- Thirdhand Tobacco Smoke: Emerging Evidence and Arguments for a Multidisciplinary Research AgendaEnvironmental Health Perspectives, 2011
- Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokersBiomarkers, 2010
- Longer term exposure to secondhand smoke and health outcomes in COPD: Impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanolNicotine & Tobacco Research, 2009
- Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposureNicotine & Tobacco Research, 2009
- Acute and Short-term Effects of Secondhand Smoke on Lung Function and Cytokine ProductionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Nicotine Chemistry, Metabolism, Kinetics and BiomarkersPublished by Springer Science and Business Media LLC ,2009
- Subpicogram per Milliliter Determination of the Tobacco-Specific Carcinogen Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Human Urine Using Liquid Chromatography−Tandem Mass SpectrometryAnalytical Chemistry, 2008
- Interindividual Differences in Hair Uptake of Air Nicotine and Significance of Cigarette Counting for Estimation of Environmental Tobacco Smoke ExposureBasic & Clinical Pharmacology & Toxicology, 1996
- Highly Sensitive Immuno-Assays for the Determination of Cotinine in Serum and Saliva. Comparison Between RIA and an Avidin-Biotin ELISAcclm, 1991
- Urine cotinine excretion in neonates exposed to tobacco smoke products in uteroThe Journal of Pediatrics, 1985